Pages that link to "Q36364465"

The following pages link to Metal complex SERMs (selective oestrogen receptor modulators). The influence of different metal units on breast cancer cell antiproliferative effects (Q36364465):

Displaying 40 items.

• Ferrocenes as potential chemotherapeutic drugs: synthesis, cytotoxic activity, reactive oxygen species production and micronucleus assay (Q30882588) (← links)
• Sawhorse-type diruthenium tetracarbonyl complexes containing porphyrin-derived ligands as highly selective photosensitizers for female reproductive cancer cells (Q33412176) (← links)
• Synthesis, characterization and cytotoxic studies of water soluble [(η-C(5)H(5))(2)Mo(thionucleobase/thionucleoside)]Cl complexes in breast and colon cancer cell lines (Q33844737) (← links)
• Organometallic anticancer compounds (Q34476685) (← links)
• Vectorized ferrocenes with estrogens and vitamin D2: synthesis, cytotoxic activity and docking studies (Q35705862) (← links)
• Targeting the estrogen receptor with metal-carbonyl derivatives of estradiol (Q35742807) (← links)
• Advances in metal-carbene complexes as potent anti-cancer agents. (Q37949533) (← links)
• Bioorganometallic Chemistry of Molybdenocene Dichloride and Its Derivatives (Q38011150) (← links)
• Targeting and delivery of platinum-based anticancer drugs (Q38050063) (← links)
• Metallocenes as Target Specific Drugs for Cancer Treatment (Q38062521) (← links)
• A golden future in medicinal inorganic chemistry: the promise of anticancer gold organometallic compounds (Q38162354) (← links)
• Regulating the anticancer properties of organometallic dendrimers using pyridylferrocene entities: synthesis, cytotoxicity and DNA binding studies (Q38770155) (← links)
• Tracking antitumor metallodrugs: promising agents with the Ru(II)- and Fe(II)-cyclopentadienyl scaffolds (Q38776872) (← links)
• Anticancer and Antibacterial Activity Studies of Gold(I)-Alkynyl Chromones. (Q38822570) (← links)
• Gold(I) NHC-based homo- and heterobimetallic complexes: synthesis, characterization and evaluation as potential anticancer agents (Q38850175) (← links)
• Functionalized ferrocenes: The role of the para substituent on the phenoxy pendant group. (Q39039204) (← links)
• Synthesis and structure-activity relationship study of organometallic bioconjugates of the cyclic octapeptide octreotate (Q39064228) (← links)
• Efficient new constructs against triple negative breast cancer cells: synthesis and preliminary biological study of ferrocifen-SAHA hybrids and related species. (Q39096632) (← links)
• Ferrocenyl catechols: synthesis, oxidation chemistry and anti-proliferative effects on MDA-MB-231 breast cancer cells. (Q39346477) (← links)
• Synthesis and cytotoxicity of a bimetallic ruthenocene dicobalt-hexacarbonyl alkyne peptide bioconjugate (Q39616731) (← links)
• Novel benzyl-substituted N-heterocyclic carbene-silver acetate complexes: synthesis, cytotoxicity and antibacterial studies (Q39623201) (← links)
• Synthesis, cytotoxicity, and COMPARE analysis of ferrocene and [3]ferrocenophane tetrasubstituted olefin derivatives against human cancer cells (Q39643708) (← links)
• Synthesis and antitumor activity of novel benzimidazole-5-carboxylic acid derivatives and their transition metal complexes as topoisomerease II inhibitors (Q39649503) (← links)
• Structural and biological investigation of ferrocene-substituted 3-methylidene-1,3-dihydro-2H-indol-2-ones (Q39890365) (← links)
• Sweetening ruthenium and osmium: organometallic arene complexes containing aspartame (Q39972474) (← links)
• Osmium carbonyl clusters: a new class of apoptosis inducing agents. (Q39988938) (← links)
• The presence of a ferrocenyl unit on an estrogenic molecule is not always sufficient to generate in vitro cytotoxicity. (Q40223467) (← links)
• Crystal structure of bis-[4-(1H-pyrrol-1-yl)phen-yl] ferrocene-1,1'-di-carboxyl-ate: a potential chemotherapeutic drug. (Q40279258) (← links)
• Antioxidative activity of ferrocenes bearing 2,6-di-tert-butylphenol moieties (Q42113294) (← links)
• New tungstenocenes containing 3-hydroxy-4-pyrone ligands: antiproliferative activity on HT-29 and MCF-7 cell lines and binding to human serum albumin studied by fluorescence spectroscopy and molecular modeling methods (Q42160954) (← links)
• Controlling Platinum, Ruthenium and Osmium Reactivity for Anticancer Drug Design. (Q42576712) (← links)
• Targeted Chemotherapy with Metal Complexes (Q43122076) (← links)
• Novel organometallic cationic ruthenium(II) pentamethylcyclopentadienyl benzenesulfonamide complexes targeted to inhibit carbonic anhydrase (Q44649427) (← links)
• Transition metal complexes with bioactive ligands: mechanisms for selective ligand release and applications for drug delivery. (Q50803523) (← links)
• Exploring metallodrug-protein interactions by mass spectrometry: comparisons between platinum coordination complexes and an organometallic ruthenium compound. (Q51767884) (← links)
• Synthesis, Characterization, and Crystal Structures of Bis-Imidazolium Salts and Respective Dinuclear Ag(I)N-Heterocyclic Carbene Complexes:In VitroAnticancer Studies against “Human Colon Cancer” and “Breast Cancer” (Q59010418) (← links)
• Classical and Non-Classical Ruthenium-Based Anticancer Drugs: Towards Targeted Chemotherapy (Q60212683) (← links)
• A brief overview of metal complexes as nuclear imaging agents (Q90299911) (← links)
• 2,2'-Bipyridine-Modified Tamoxifen: A Versatile Vector for Molybdacarboranes (Q91065615) (← links)
• Rationally Designed Ruthenium Complexes for Breast Cancer Therapy (Q92635109) (← links)